rs10405121 — CACNA1A

Common intronic variant in CACNA1A — the P/Q-type calcium channel gene mutated in familial hemiplegic migraine — that reaches genome-wide significance for migraine with aura; the G (reference) allele confers typical susceptibility while the A allele is mildly protective

See your personal result for CACNA1A

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

CACNA1A — The Hemiplegic Migraine Gene and the First Common Risk Variant for Migraine with Aura

CACNA1A11 CACNA1A
calcium voltage-gated channel subunit alpha1-A; encodes the pore-forming subunit of P/Q-type voltage-gated calcium channels expressed predominantly in cerebellar Purkinje cells and cortical and brainstem neurons is one of the best-characterised neurological genes in genetics. Rare, highly penetrant mutations in this gene cause three distinct Mendelian disorders: familial hemiplegic migraine type 1 (FHM1), episodic ataxia type 2 (EA2), and spinocerebellar ataxia type 6 (SCA6). The same gene now yields a common population-level risk variant for ordinary migraine with aura — rs10405121 — making it the bridge between rare channelopathies and the genetic architecture of one of the world's most prevalent neurological conditions.

rs10405121 sits in an intron of CACNA1A on chromosome 19 (GRCh38 position 13,228,314). It does not change the protein sequence. Its biological effect is presumed to operate through altered splicing efficiency or regulatory element function within the intronic sequence, modulating CACNA1A expression levels in neurons. The G allele — the population-common reference allele present in about 55–66% of chromosomes across populations — is the allele associated with slightly higher migraine susceptibility, while the A allele confers modest protection.

The Mechanism

P/Q-type calcium channels encoded by CACNA1A22 encoded by CACNA1A
the alpha-1A subunit forms the ion-conducting pore; the channel is the primary route for calcium entry at presynaptic terminals in neurons of the cerebellum, cortex, and trigeminovascular system control neurotransmitter release at excitatory synapses throughout the brain. In the trigeminovascular system — the nerve network that carries pain signals from meningeal vessels to the trigeminal nucleus — P/Q-type channels regulate the threshold for cortical spreading depression33 cortical spreading depression
CSD; a slow wave of neuronal and glial depolarization that propagates across the cortex at 3-5 mm/min and is believed to be the electrophysiological correlate of the migraine aura. Rare FHM1 mutations in CACNA1A increase channel gain-of-function, lowering the CSD threshold and accounting for the aura phenotype that characterises FHM1. The common rs10405121 variant likely exerts an analogous but quantitatively far smaller effect — enough to shift the population distribution of CSD threshold rather than to cause hemiplegic episodes.

The Evidence

The primary evidence is from Hautakangas et al. 202244 Hautakangas et al. 2022
Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles. Nature Genetics, the largest migraine GWAS published to date. In this meta-analysis of 102,084 cases and 771,257 controls, rs10405121 reached genome-wide significance for migraine overall (G allele: OR 1.034, 95% CI 1.02–1.04, p = 5×10⁻¹⁰). Crucially, stratification using 29,679 cases with subtype information identified the CACNA1A locus — along with HMOX2 and MPPED2 — as appearing specific for migraine with aura rather than migraine without aura. This is the first common variant in CACNA1A to reach genome-wide significance for migraine and places rs10405121 in a biologically coherent position: a regulatory intronic variant in the gene whose rare mutations define FHM1, an aura-prominent condition.

A smaller case-control study (Szymanowicz et al. 202555 Szymanowicz et al. 2025
CACNA1A Genetic Variants and Their Potential Involvement in Migraine Pathogenesis. Int J Mol Sci, n = 150) found that the rs10405121 AA genotype occurred exclusively in familial migraine cases, suggesting that the protective A allele homozygote is enriched in individuals without strong family history. However, this study's small sample size means it should be interpreted cautiously alongside the large GWAS data.

Practical Actions

The effect size for rs10405121 is modest (OR 1.034 per G allele), meaning that genotype alone is a minor contributor to individual migraine risk. The clinical value lies in understanding which calcium channel pathway underlies aura susceptibility — relevant when choosing preventive medications. Calcium channel blockers, particularly flunarizine66 flunarizine
a selective calcium channel antagonist approved for migraine prevention in Europe and many other countries; inhibits L-type and T-type channels and has indirect modulation of P/Q-type channel activity, target the same calcium channel biology and represent a pharmacologically rational preventive option for GG or AG individuals who experience frequent migraine with aura.

For those carrying two G alleles who experience migraine with aura: calcium channel-modulating preventives may be worth discussing with a neurologist, as the CACNA1A biological pathway is directly implicated.

Interactions

CACNA1A is one of several ion channel genes in the GeneOps neurology-cognition database with migraine relevance. rs10166942 in TRPM8 (a cold-sensing channel upregulated in trigeminal neurons) is independently associated with migraine susceptibility and operates through a distinct receptor pathway. rs8065080 (SCN1A, a sodium channel gene) is also in the migraine genetic architecture. Individuals carrying risk variants at multiple ion channel loci may have an additive susceptibility load, though no published compound interaction data exist specifically for rs10405121 with these variants.

The rare FHM1-causing CACNA1A mutations (e.g., R192Q, T666M) are not captured by rs10405121 — they are rare pathogenic coding variants typically identified by clinical sequencing, not population genotyping.

Drug Interactions

flunarizine dose_adjustment literature
topiramate dose_adjustment literature

Genotype Interpretations

What each possible genotype means for this variant.

GG Typical Risk Normal

Common CACNA1A genotype — typical background migraine susceptibility

You carry two copies of the G allele at rs10405121, which is the most common genotype globally (approximately 43% of people). G is the GRCh38 reference allele and the allele associated with typical-to-slightly-elevated migraine susceptibility in the Hautakangas 2022 GWAS. The per-allele odds ratio is modest (OR 1.034), meaning your genotype is the reference baseline for migraine risk in the general population — neither strongly elevated nor protected. This genotype was identified as migraine-with-aura-specific in the subtype stratification, so if you experience aura, this genetic background is part of that story.

AA Most Protected Beneficial

Two A alleles — lowest migraine susceptibility at this CACNA1A locus

The protective effect of the A allele is most relevant for migraine with aura specifically. Hautakangas et al. 2022 identified the CACNA1A locus as one of only three loci appearing specific for migraine with aura (versus migraine without aura or migraine overall). This means your AA genotype's protection is particularly strong for the aura subtype — though it does not eliminate the possibility of migraine through other genetic or environmental routes.

A small case-control study (Szymanowicz et al. 2025, n=150) found the AA genotype absent in familial migraine cases and present only in non-familial cases and controls — directionally consistent with the large GWAS finding that A is protective. The Szymanowicz study is too small for definitive conclusions, but supports the protective interpretation.

The per-allele OR of 1.034 means the absolute protection from homozygous AA (compared to GG) is approximately a 6-7% reduction in odds — modest but real in a condition as prevalent as migraine.

AG One Protective Allele Intermediate

One A allele — mildly reduced migraine susceptibility compared to GG

The Hautakangas 2022 GWAS (102,084 cases, 771,257 controls) found that rs10405121 G is the risk allele with OR 1.034. The inverse — that each A allele reduces risk by a corresponding amount — follows directly. Heterozygotes carrying one A allele sit between the GG (reference risk) and AA (maximal protection) states. The aura-specific nature of the CACNA1A association means this modest protection is particularly relevant to migraine-with-aura phenotype.

The calcium channel biology underlying this locus means that if you do experience migraine, the CACNA1A pathway may still contribute — having one protective allele does not eliminate channel-mediated susceptibility entirely.